Bank of America
EDIT icon

Bank of America’s Editas Medicine EDIT Stock Holding History

Bank of America’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$333K Sell
134,866
-58,809
-30% -$124K ﹤0.01% 5102
2025
Q4 		$397K Sell
193,675
-830,565
-81% -$2.4M ﹤0.01% 5035
2025
Q3 		$3.55M Sell
1,024,240
-55,456
-5% -$155K ﹤0.01% 4336
2025
Q2 		$2.38M Sell
1,079,696
-437,959
-29% -$717K ﹤0.01% 4620
2025
Q1 		$1.76M Buy
1,517,655
+1,084,483
+250% +$1.6M ﹤0.01% 4782
2024
Q4 		$550K Sell
433,172
-449,067
-51% -$1.14M ﹤0.01% 5456
2024
Q3 		$3.01M Buy
882,239
+342,513
+63% +$1.49M ﹤0.01% 4207
2024
Q2 		$2.52M Sell
539,726
-356,921
-40% -$2.01M ﹤0.01% 4255
2024
Q1 		$6.65M Buy
896,647
+524,563
+141% +$4.36M ﹤0.01% 3371
2023
Q4 		$3.77M Buy
372,084
+43,556
+13% +$382K ﹤0.01% 3786
2023
Q3 		$2.56M Sell
328,528
-99,605
-23% -$854K ﹤0.01% 4028
2023
Q2 		$3.52M Sell
428,133
-513,762
-55% -$4.48M ﹤0.01% 3718
2023
Q1 		$6.83M Buy
941,895
+80,730
+9% +$718K ﹤0.01% 3212
2022
Q4 		$7.64M Buy
861,165
+402,363
+88% +$4.42M ﹤0.01% 2953
2022
Q3 		$5.62M Buy
458,802
+163,966
+56% +$2.55M ﹤0.01% 3225
2022
Q2 		$3.49M Sell
294,836
-10,193
-3% -$137K ﹤0.01% 3768
2022
Q1 		$5.8M Buy
305,029
+32,084
+12% +$596K ﹤0.01% 3468
2021
Q4 		$7.25M Sell
272,945
-29,983
-10% -$1.03M ﹤0.01% 3278
2021
Q3 		$12.4M Buy
302,928
+60,802
+25% +$3.33M ﹤0.01% 2618
2021
Q2 		$13.7M Buy
242,126
+29,069
+14% +$1.07M ﹤0.01% 2511
2021
Q1 		$8.95M Buy
213,057
+79,572
+60% +$4.53M ﹤0.01% 2834
2020
Q4 		$9.36M Buy
133,485
+99,535
+293% +$4.09M ﹤0.01% 2544
2020
Q3 		$952K Sell
33,950
-83,573
-71% -$2.72M ﹤0.01% 4254
2020
Q2 		$3.48M Buy
117,523
+76,584
+187% +$2M ﹤0.01% 3179
2020
Q1 		$812K Buy
40,939
+13,915
+51% +$351K ﹤0.01% 4160
2019
Q4 		$800K Sell
27,024
-9,521
-26% -$238K ﹤0.01% 4651
2019
Q3 		$831K Sell
36,545
-68,777
-65% -$1.7M ﹤0.01% 4683
2019
Q2 		$2.61M Sell
105,322
-66,733
-39% -$1.59M ﹤0.01% 3821
2019
Q1 		$4.21M Buy
172,055
+136,529
+384% +$3.09M ﹤0.01% 3321
2018
Q4 		$809K Sell
35,526
-31,059
-47% -$845K ﹤0.01% 4578
2018
Q3 		$2.12M Sell
66,585
-29,882
-31% -$966K ﹤0.01% 3931
2018
Q2 		$3.46M Buy
96,467
+34,837
+57% +$1.23M ﹤0.01% 3502
2018
Q1 		$2.04M Buy
61,630
+15,294
+33% +$545K ﹤0.01% 3867
2017
Q4 		$1.42M Sell
46,336
-1,679
-3% -$42.3K ﹤0.01% 4237
2017
Q3 		$1.15M Buy
48,015
+39,871
+490% +$759K ﹤0.01% 4409
2017
Q2 		$136K Buy
8,144
+2,208
+37% +$39.8K ﹤0.01% 5488
2017
Q1 		$133K Buy
5,936
+2,489
+72% +$51.6K ﹤0.01% 5501
2016
Q4 		$56K Buy
3,447
+2,412
+233% +$36.6K ﹤0.01% 5876
2016
Q3 		$14K Sell
1,035
-203
-16% -$4.16K ﹤0.01% 6257
2016
Q2 		$30K Sell
1,238
-1,165
-48% -$39.3K ﹤0.01% 6071
2016
Q1 		$83K Buy
+2,403
New +$63.2K ﹤0.01% 5564

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America's EDIT Position: Q1 2026 in Review

Bank of America reduced its Editas Medicine (EDIT) stake by 30% in Q1 2026, selling an estimated $124K and leaving 134,866 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #5102.

Bank of America first reported a position in EDIT in Q1 2016 and has held it in 41 quarters since. The position peaked at $13.7M in Q2 2021. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Bank of America held 134,866 shares of Editas Medicine worth $333K as of Q1 2026.
  • Bank of America sold 58,809 Editas Medicine shares in Q1 2026, an estimated $124K.
  • Editas Medicine made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5102 holding.
  • Bank of America first reported a position in Editas Medicine in Q1 2016 and has held it in 41 quarters since.
  • Bank of America's Editas Medicine position peaked at $13.7M in Q2 2021.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.